Hospitals use the iPad to heal, inform and more (Weekend Rounds)

Life science current events this week include five ways hospitals are using the iPad, how to navigate the European regulatory environment and the long road ahead for the artificial pancreas for diabetes.

A review of life science current events reported by MedCity News this week:

Five ways hospitals are using the iPad. We’ve chosen to highlight five ways hospitals are using the iPad — to heal, to inform, to make money, to impart their history and to educate — and offered examples of each.

Medical devices: Four tips on navigating the European regulatory environment. Due to complaints about the U.S. Food and Drug Administration’s perceived inconsistency, risk aversion and foot-dragging, many in the device industry have turned to the European Union’s CE Mark for their initial regulatory approval. A survey earlier this year by Northwestern University researchers found that two-thirds of small American med-tech firms are getting European market approval first, compared with only 4 percent who report going the domestic route first and getting FDA approval.

Diabetes’ artificial pancreas still faces a long, bumpy road. As Medtronic prepares to begin the first U.S. trial of a low-glucose suspense system, and as diabetes device companies, researchers and advocates look to the U.S. Food and Drug Administration for guidance, one thing is obvious: The United States is way behind in giving patients access to the Holy Grail of type 1 diabetes treatment, the artificial pancreas.

Spine fusion device startup eyes Cleveland move, more funding. OrthoData is hoping to attract some Northeast Ohio investors to help pave the way for the relocation. The company would also use a hoped-for $7 million series B round of investment to fund animal and human testing of its implantable electronic spine fusion sensor, said CEO Ric Navarro, a Northeast Ohio native who was previously an executive with Integra Spine.

RTI lands $60M contract with CDC for public health program. Research Triangle Park, North Carolina-based RTI will evaluate the CDC’s Community Transformation Grant program, or CTG, which provides grants that implement policy or environmental changes targeting chronic diseases, secondary conditions such as diabetes and health disparities.